{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:41:11Z","timestamp":1707525671876},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,24]]},"DOI":"10.7759\/cureus.52858","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T15:01:29Z","timestamp":1706108489000},"source":"Crossref","is-referenced-by-count":0,"title":["Unusual Presentation of a Hepatic Neuroendocrine Tumor With Elevated CEA and CA 19\u20139: A Case Report"],"prefix":"10.7759","author":[{"given":"Eli","family":"Zolotov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Hazaveh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanisha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfa","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi G","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, et al.. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022, 33:115-54. 10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21493","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives M","year":"2018","unstructured":"Cives M, Strosberg JR. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2018, 68:471-87. 10.3322\/caac.21493","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0082-5","article-title":"Role of biomarker tests for diagnosis of neuroendocrine tumours","volume":"14","author":"Hofland J","year":"2018","unstructured":"Hofland J, Zandee WT, de Herder WW. Role of biomarker tests for diagnosis of neuroendocrine tumours. Nat Rev Endocrinol. 2018, 14:656-69. 10.1038\/s41574-018-0082-5","journal-title":"Nat Rev Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2019.11.003","article-title":"A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood","volume":"31","author":"\u00d6berg K","year":"2020","unstructured":"\u00d6berg K, Califano A, Strosberg JR, et al.. A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood. Ann Oncol. 2020, 31:202-12. 10.1016\/j.annonc.2019.11.003","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(98)00303-1","article-title":"Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?","volume":"177","author":"Bakalakos EA","year":"1999","unstructured":"Bakalakos EA, Burak WE Jr, Young DC, Martin EW Jr. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?. Am J Surg. 1999, 177:2-6. 10.1016\/s0002-9610(98)00303-1","journal-title":"Am J Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-011-0042-1","article-title":"Serum CA 19-9 as a Biomarker for pancreatic cancer-a comprehensive review","volume":"2","author":"Ballehaninna UK","year":"2011","unstructured":"Ballehaninna UK, Chamberlain RS. Serum CA 19-9 as a Biomarker for pancreatic cancer-a comprehensive review. Indian J Surg Oncol. 2011, 2:88-100. 10.1007\/s13193-011-0042-1","journal-title":"Indian J Surg Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31079","article-title":"Neuroendocrine tumors and fibrosis: an unsolved mystery?","volume":"123","author":"Laskaratos FM","year":"2017","unstructured":"Laskaratos FM, Rombouts K, Caplin M, Toumpanakis C, Thirlwell C, Mandair D. Neuroendocrine tumors and fibrosis: an unsolved mystery?. Cancer. 2017, 123:4770-90. 10.1002\/cncr.31079","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/02841869309083898","article-title":"Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system","volume":"32","author":"Chaudhry A","year":"1993","unstructured":"Chaudhry A, Funa K, Oberg K. Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system. Acta Oncol. 1993, 32:107-14. 10.3109\/02841869309083898","journal-title":"Acta Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.616337","article-title":"A rare case of acute liver failure secondary to diffuse hepatic infiltration of small cell neuroendocrine carcinoma","volume":"11","author":"Yan P","year":"2021","unstructured":"Yan P, Liu Y, Wang Q, Chen X. A rare case of acute liver failure secondary to diffuse hepatic infiltration of small cell neuroendocrine carcinoma. Front Oncol. 2021, 11:616337. 10.3389\/fonc.2021.616337","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v3.i10.144","article-title":"TTF-1 positive small cell cancers: don't think they're always primary pulmonary!","volume":"3","author":"Verset L","year":"2011","unstructured":"Verset L, Arvanitakis M, Loi P, Closset J, Delhaye M, Remmelink M, Demetter P. TTF-1 positive small cell cancers: don't think they're always primary pulmonary!. World J Gastrointest Oncol. 2011, 3:144-7. 10.4251\/wjgo.v3.i10.144","journal-title":"World J Gastrointest Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000020289","article-title":"Low PSA metastatic androgen- independent prostate cancer","volume":"38","author":"Sella A","year":"2000","unstructured":"Sella A, Konichezky M, Flex D, Sulkes A, Baniel J. Low PSA metastatic androgen- independent prostate cancer. Eur Urol. 2000, 38:250-4. 10.1159\/000020289","journal-title":"Eur Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-008778","article-title":"Malignant neuroendocrine tumour of the gallbladder with elevated carcinoembryonic antigen: case report and literature review","volume":"2013","author":"Furrukh M","year":"2013","unstructured":"Furrukh M, Qureshi A, Saparamadu A, Kumar S. Malignant neuroendocrine tumour of the gallbladder with elevated carcinoembryonic antigen: case report and literature review. BMJ Case Rep. 2013, 2013:bcr2013008778. 10.1136\/bcr-2013-008778","journal-title":"BMJ Case Rep"},{"key":"ref13","article-title":"Malignant carcinoid tumor of the appendix with liver and lung metastasis: report of a case with a high level of serum carcinoembryonic antigen","volume":"83","author":"Panomreongsak P","year":"2000","unstructured":"Panomreongsak P, Sthapanachai C, Sukpanichnant S, et al.. Malignant carcinoid tumor of the appendix with liver and lung metastasis: report of a case with a high level of serum carcinoembryonic antigen. J Med Assoc Thai. 2000, 83:97-102.","journal-title":"J Med Assoc Thai"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4021\/wjon341w","article-title":"Primary hepatic neuroendocrine tumor: what do we know now?","volume":"2","author":"Quartey B","year":"2011","unstructured":"Quartey B. Primary hepatic neuroendocrine tumor: what do we know now?. World J Oncol. 2011, 2:209-16. 10.4021\/wjon341w","journal-title":"World J Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2019.03.009","article-title":"Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors","volume":"18","author":"Li MX","year":"2019","unstructured":"Li MX, Li QY, Xiao M, et al.. Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors. Hepatobiliary Pancreat Dis Int. 2019, 18:538-45. 10.1016\/j.hbpd.2019.03.009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19990901)86:5<858::aid-cncr23>3.0.co;2-8","article-title":"Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors","volume":"86","author":"Bajetta E","year":"1999","unstructured":"Bajetta E, Ferrari L, Martinetti A, et al.. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer. 1999, 86:858-65. 10.1002\/(sici)1097-0142(19990901)86:5&lt;858::aid-cncr23&gt;3.0.co;2-8","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.1999.00866.x","article-title":"Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases","volume":"49","author":"Pilichowska M","year":"1999","unstructured":"Pilichowska M, Kimura N, Ouchi A, Lin H, Mizuno Y, Nagura H. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathol Int. 1999, 49:318-24. 10.1046\/j.1440-1827.1999.00866.x","journal-title":"Pathol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/219238-unusual-presentation-of-a-hepatic-neuroendocrine-tumor-with-elevated-cea-and-ca-19-9-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:31Z","timestamp":1707509551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/219238-unusual-presentation-of-a-hepatic-neuroendocrine-tumor-with-elevated-cea-and-ca-19-9-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.52858","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,24]]}}}